Here's the live share price of Zydus Lifesciences along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Zydus Lifesciences has gained 23.37% CAGR. Over the past year, the corresponding return has been -6.58%.
Zydus Lifesciences’s current P/E of 22.81x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
---|---|---|---|---|---|---|---|
Zydus Lifesciences | 2.70 | 8.78 | 6.19 | 15.50 | -6.55 | 40.27 | 23.37 |
Sun Pharmaceutical Industries | 0.71 | -1.18 | -5.78 | -3.74 | -13.69 | 21.56 | 25.72 |
Divi's Laboratories | -1.69 | 0.72 | -10.22 | 8.84 | 10.92 | 17.94 | 13.82 |
Cipla | -0.88 | 4.01 | 2.74 | 8.12 | -3.93 | 13.67 | 16.54 |
Torrent Pharmaceuticals | -0.18 | -0.66 | 11.98 | 17.33 | 4.46 | 33.54 | 20.59 |
Dr. Reddy's Laboratories | 4.05 | 6.97 | -3.43 | 16.78 | -1.37 | 15.22 | 8.29 |
Mankind Pharma | 1.32 | 6.71 | 9.33 | 17.63 | 6.84 | 22.22 | 12.79 |
Lupin | 1.97 | 1.62 | -2.46 | 0.07 | -10.47 | 43.34 | 15.50 |
Abbott India | -2.94 | -5.31 | -1.18 | 2.43 | 5.95 | 19.91 | 13.60 |
Alkem Laboratories | 0.28 | 9.84 | 8.85 | 11.38 | -15.21 | 18.41 | 12.73 |
Aurobindo Pharma | 1.55 | -0.15 | -9.39 | -3.65 | -30.25 | 24.03 | 5.56 |
Glenmark Pharmaceuticals | 6.80 | 3.81 | 29.94 | 51.80 | 23.04 | 76.01 | 35.20 |
Biocon | 2.03 | 6.46 | 2.78 | 10.70 | -5.51 | 6.27 | -3.29 |
Laurus Labs | 2.47 | 7.66 | 32.25 | 55.91 | 76.72 | 17.85 | 29.33 |
GlaxoSmithKline Pharmaceuticals | -0.62 | 5.02 | -16.45 | 6.31 | -1.13 | 25.70 | 11.08 |
Anthem Biosciences | -3.38 | 8.21 | 11.66 | 11.66 | 11.66 | 3.74 | 2.23 |
Cohance Lifesciences | 9.99 | 5.19 | -1.29 | -14.42 | -16.97 | 27.61 | 23.66 |
Ipca Laboratories | -1.66 | -1.59 | -5.28 | 1.97 | -8.32 | 14.57 | 5.12 |
Ajanta Pharma | -0.27 | -2.02 | -2.01 | 3.08 | -23.52 | 23.33 | 20.85 |
Gland Pharma | 0.68 | -1.87 | 13.00 | 18.05 | 0.55 | -7.02 | 0.86 |
Over the last one year, Zydus Lifesciences has declined 6.55% compared to peers like Sun Pharmaceutical Industries (-13.69%), Divi's Laboratories (10.92%), Cipla (-3.93%). From a 5 year perspective, Zydus Lifesciences has outperformed peers relative to Sun Pharmaceutical Industries (25.72%) and Divi's Laboratories (13.82%).
Day | SMA | EMA |
---|---|---|
5 | 997.61 | 1,016.82 |
10 | 995.09 | 1,007.08 |
20 | 980.64 | 995.98 |
50 | 979.15 | 979.5 |
100 | 945.33 | 964.59 |
200 | 943.75 | 957.91 |
In the latest quarter, Zydus Lifesciences remained same as its previous close in promoter holding, while DII stake increased to 11.13%, FII holding fell to 7.13%, and public shareholding moved up to 6.74% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
---|---|---|---|
Parag Parikh Flexi Cap Fund | 1,44,70,385 | 1.24 | 1,403.34 |
Kotak Flexicap Fund - Regular Plan | 1,05,00,000 | 1.91 | 1,018.29 |
ICICI Prudential Bluechip Fund | 43,91,979 | 0.59 | 425.93 |
ICICI Prudential Value Discovery Fund | 24,53,872 | 0.44 | 237.98 |
ICICI Prudential India Opportunities Fund | 22,80,577 | 0.74 | 221.17 |
Nippon India Pharma Fund | 20,00,632 | 2.22 | 194.02 |
ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund | 18,71,599 | 2.97 | 181.51 |
Sundaram Mid Cap Fund | 11,24,810 | 0.87 | 109.08 |
ICICI Prudential Large & Mid Cap Fund | 10,56,117 | 0.44 | 102.42 |
ICICI Prudential Nifty Next 50 Index Fund | 8,27,691 | 1.04 | 80.27 |
Price | (%) As on Invalid Date IST |
Open Interest | (%) |
High | |
Low | |
Open | |
Close | |
Contract Traded | |
Turnover (in lakhs) |
Date Time | Announcement |
---|---|
Sep 06, 2025, 1:02 AM IST | Zydus Lifesciences - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
Sep 05, 2025, 3:15 PM IST | Zydus Lifesciences - Announcement under Regulation 30 (LODR)-Change in Management |
Sep 04, 2025, 9:23 PM IST | Zydus Lifesciences - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
Sep 02, 2025, 5:31 AM IST | Zydus Lifesciences - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
Aug 29, 2025, 4:22 PM IST | Zydus Lifesciences - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
Zydus Lifesciences Ltd. is a Public Limited Listed company incorporated on 15/05/1995 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24230GJ1995PLC025878 and registration number is 025878. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 15116.30 Cr. and Equity Capital is Rs. 100.60 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Zydus Lifesciences is ₹1,039.35 as on Sep 10, 2025.
The Zydus Lifesciences is operating in the Pharmaceuticals and health care Sector. It is classified as a Largecap stock on the BSE.
The market cap of Zydus Lifesciences is ₹104,582.93 Cr as on Sep 10, 2025.
Today’s highest and lowest price of Zydus Lifesciences are ₹1,049.80 and ₹1,033.00.
The 52-week high/low is the highest and lowest price at which Zydus Lifesciences stock has traded in the past 52-week or nearly a year. The 52-week high of Zydus Lifesciences is ₹1,135.95 and 52-week low of Zydus Lifesciences is ₹797.05 as on Sep 10, 2025.
The Zydus Lifesciences has shown returns of 0.26% over the past day, 8.78% for the past month, 5.88% over 3 months, -6.58% over 1 year, 40.27% across 3 years, and 23.37% over 5 years.
P/E ratio of and PB ratio of Zydus Lifesciences are 22.81 and 4.79 on Sep 10, 2025. While the company gives a dividend yield of 1.06 per annum.